Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bartsch

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancer Research|May 1, 1998
Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell linesB Simon, D Bartsch, P Barth, et al.
Deutsche Medizinische Wochenschrift (1946)|January 20, 1999
[Germline mutations in the MEN1 gene: basis for predictive genetic screening and clinical management of multiple endocrine neoplasia type 1 (MEN1) families]D Bartsch, I Kopp, A Bergenfelz, et al.
Genes, Chromosomes & Cancer|November 1, 1995
Frequent mutations of CDKN2 in primary pancreatic adenocarcinomasD Bartsch, D W Shevlin, W S Tung, et al.
Molecular Carcinogenesis|January 1, 1996
Infrequent CDKN2 mutation in human differentiated thyroid cancersW S Tung, D W Shevlin, D Bartsch, et al.
Molecular Carcinogenesis|August 1, 1995
Low frequency of CDKN2 mutation in endometrial carcinomasS L Peiffer, D Bartsch, A J Whelan, et al.
Journal of the National Cancer Institute|May 15, 1996
Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutationD Bartsch, D W Shevlin, M P Callery, et al.
Die Nahrung|January 1, 1976
[Rheology and spinning of alkaline solution of field bean protein and casein]H Schmandke, D Paul, H J Gensrich, et al.
Annals of Surgery|July 22, 1998
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreasD Bartsch, D Bastian, P Barth, et al.
Cancer Letters|July 17, 1999
Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomasD Bartsch, P Barth, D Bastian, et al.
Cell|June 18, 1998
Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brainB Santoro, D T Liu, H Yao, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancer Research|May 1, 1998
Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell linesB Simon, D Bartsch, P Barth, et al.
Deutsche Medizinische Wochenschrift (1946)|January 20, 1999
[Germline mutations in the MEN1 gene: basis for predictive genetic screening and clinical management of multiple endocrine neoplasia type 1 (MEN1) families]D Bartsch, I Kopp, A Bergenfelz, et al.
Genes, Chromosomes & Cancer|November 1, 1995
Frequent mutations of CDKN2 in primary pancreatic adenocarcinomasD Bartsch, D W Shevlin, W S Tung, et al.
Molecular Carcinogenesis|January 1, 1996
Infrequent CDKN2 mutation in human differentiated thyroid cancersW S Tung, D W Shevlin, D Bartsch, et al.
Molecular Carcinogenesis|August 1, 1995
Low frequency of CDKN2 mutation in endometrial carcinomasS L Peiffer, D Bartsch, A J Whelan, et al.
Journal of the National Cancer Institute|May 15, 1996
Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutationD Bartsch, D W Shevlin, M P Callery, et al.
Die Nahrung|January 1, 1976
[Rheology and spinning of alkaline solution of field bean protein and casein]H Schmandke, D Paul, H J Gensrich, et al.
Annals of Surgery|July 22, 1998
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreasD Bartsch, D Bastian, P Barth, et al.
Cancer Letters|July 17, 1999
Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomasD Bartsch, P Barth, D Bastian, et al.
Cell|June 18, 1998
Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brainB Santoro, D T Liu, H Yao, et al.
Pageof 10